ACADIA Pharmaceuticals Inc.

Historical 13F Holders

Symbol
ACAD
CUSIP
004225108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 004225108 since 12/18/2024, largest first.

Filer % of Class Filed
Baker Bros. Advisors LP 13D/A
25.4% 2/26/2026
Event 2/24/2026
BlackRock, Inc. 13G/A 11.9% 2/7/2025
Event 1/31/2025
Vanguard Portfolio Management LLC 13G 5.2% 4/28/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
State Street Corp 13G 4.4% 11/10/2026
Event 9/30/2026
RTW Investments, LP 13G/A
4.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 180 21.0 M $423M
2026 Q2 355 169 M $4.27B
2026 Q1 348 165 M $3.67B
2025 Q4 341 166 M $4.44B
2025 Q3 347 168 M $3.58B
2025 Q2 317 170 M $3.66B
2025 Q1 325 173 M $2.87B
2024 Q4 299 163 M $2.99B
2024 Q3 261 156 M $2.40B
2024 Q2 267 161 M $2.62B
2024 Q1 272 162 M $2.99B
2023 Q4 281 160 M $4.99B
2023 Q3 252 156 M $3.25B
2023 Q2 240 159 M $3.81B
2023 Q1 235 158 M $2.97B
2022 Q4 230 156 M $2.76B
2022 Q3 227 152 M $2.49B
2022 Q2 252 151 M $2.13B
2022 Q1 265 147 M $3.56B
2021 Q4 253 148 M $3.46B
2021 Q3 241 145 M $2.41B
2021 Q2 249 148 M $3.61B
2021 Q1 278 145 M $3.76B
2020 Q4 311 148 M $7.90B
2020 Q3 272 150 M $6.19B
2020 Q2 301 153 M $7.40B
2020 Q1 251 154 M $6.51B
2019 Q4 280 150 M $6.41B
2019 Q3 237 147 M $5.28B
2019 Q2 203 138 M $3.70B
2019 Q1 204 138 M $3.70B
2018 Q4 190 140 M $2.26B
2018 Q3 191 122 M $2.53B
2018 Q2 191 119 M $1.82B
2018 Q1 201 122 M $2.74B
2017 Q4 215 120 M $3.61B
2017 Q3 218 118 M $4.44B
2017 Q2 208 120 M $3.34B
2017 Q1 225 120 M $4.11B
2016 Q4 234 121 M $3.50B
2016 Q3 241 118 M $3.75B
2016 Q2 233 111 M $3.61B
2016 Q1 220 111 M $3.09B
2015 Q4 217 101 M $3.61B
2015 Q3 190 98.7 M $3.31B
2015 Q2 193 98.3 M $4.12B
2015 Q1 195 97.3 M $3.17B
2014 Q4 182 96.3 M $3.06B
2014 Q3 163 94.2 M $2.33B
2014 Q2 162 95.1 M $2.15B
2014 Q1 168 90.9 M $2.21B